Biomarin Pharmaceutical Inc.
15 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Biomarin Pharmaceutical Inc.
Federal lobbying records
Bills it lobbied on8 of 9
HR 1509 Accelerating Kids’ Access to Care Act of 20258 reports · In committeeHR 1262 Mikaela Naylon Give Kids a Chance Act8 reports · Passed one chamberS 1637 MVP Act6 reports · In committeeS 752 Accelerating Kids’ Access to Care Act6 reports · In committeeS 932 Give Kids a Chance Act of 20254 reports · In committeeHR 1 An act to provide for reconciliation pursuant to title II of H. Con. Res. 142 reports · Became lawHR 5371 Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 20262 reports · Became lawS 1862 ORPHAN Cures Act2 reports · In committeeEvery link on this map
The same connections as a table, with the reason each one is here.
| HR 1509 | Bills it lobbied on | Biomarin Pharmaceutical Inc. named HR 1509, “Accelerating Kids’ Access to Care Act of 2025”, in 8 lobbying reports. | 8 reports |
| HR 1262 | Bills it lobbied on | Biomarin Pharmaceutical Inc. named HR 1262, “Mikaela Naylon Give Kids a Chance Act”, in 8 lobbying reports. | 8 reports |
| S 1637 | Bills it lobbied on | Biomarin Pharmaceutical Inc. named S 1637, “MVP Act”, in 6 lobbying reports. | 6 reports |
| S 752 | Bills it lobbied on | Biomarin Pharmaceutical Inc. named S 752, “Accelerating Kids’ Access to Care Act”, in 6 lobbying reports. | 6 reports |
| S 932 | Bills it lobbied on | Biomarin Pharmaceutical Inc. named S 932, “Give Kids a Chance Act of 2025”, in 4 lobbying reports. | 4 reports |
| HR 1 | Bills it lobbied on | Biomarin Pharmaceutical Inc. named HR 1, “An act to provide for reconciliation pursuant to title II of H. Con. Res. 14”, in 2 lobbying reports. | 2 reports |
| HR 5371 | Bills it lobbied on | Biomarin Pharmaceutical Inc. named HR 5371, “Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026”, in 2 lobbying reports. | 2 reports |
| S 1862 | Bills it lobbied on | Biomarin Pharmaceutical Inc. named S 1862, “ORPHAN Cures Act”, in 2 lobbying reports. | 2 reports |
| Markwayne Mullin | Lawmakers it funded or lobbied | Markwayne Mullin leads 2 bills Biomarin Pharmaceutical Inc. lobbied on. | Leads 2 of these bills |
| Charles Grassley | Lawmakers it funded or lobbied | Charles Grassley leads 1 bill Biomarin Pharmaceutical Inc. lobbied on. | Leads 1 of these bills |
| Jodey Arrington | Lawmakers it funded or lobbied | Jodey Arrington leads 1 bill Biomarin Pharmaceutical Inc. lobbied on. | Leads 1 of these bills |
| John Barrasso | Lawmakers it funded or lobbied | John Barrasso leads 1 bill Biomarin Pharmaceutical Inc. lobbied on. | Leads 1 of these bills |
| Lori Trahan | Lawmakers it funded or lobbied | Lori Trahan leads 1 bill Biomarin Pharmaceutical Inc. lobbied on. | Leads 1 of these bills |
| Michael McCaul | Lawmakers it funded or lobbied | Michael McCaul leads 1 bill Biomarin Pharmaceutical Inc. lobbied on. | Leads 1 of these bills |
| Tom Cole | Lawmakers it funded or lobbied | Tom Cole leads 1 bill Biomarin Pharmaceutical Inc. lobbied on. | Leads 1 of these bills |